Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes

Atherosclerosis
Maria F Lopes-VirellaDCCT/EDIC Research Group

Abstract

Modified lipoproteins induce autoimmune responses including the synthesis of autoantibodies with pro-inflammatory characteristics. Circulating modified lipoprotein autoantibodies combine with circulating antigens and form immune complexes (IC). We now report the results of a study investigating the role of circulating IC containing modified lipoproteins in the progression of carotid intima-media thickness (IMT) in patients enrolled in the Epidemiology of Diabetes Interventions and Complications (EDIC) Trial, a follow-up study of the Diabetes Control and Complications Trial (DCCT). This cohort includes 1229 patients with type 1 diabetes in whom B-mode ultrasonography of internal and common carotid arteries was performed in 1994-1996 and in 1998-2000. Conventional CHD risk factors, antibodies against modified forms of LDL and modified lipoprotein IC were determined in 1050 of these patients from blood collected in 1996-1998. Cholesterol and apolipoprotein B content of IC (surrogate markers of modified ApoB-rich lipoproteins) were significantly higher in patients who showed progression of the internal carotid IMT than in those showing no progression, regression or mild progression. Multivariate linear and logistic regression model...Continue Reading

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Oct 1, 1978·Analytical Biochemistry·A Hara, N S Radin
May 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·W PalinskiJ L Witztum
Jun 1, 1990·Experimental and Molecular Pathology·V V TertovV N Smirnov
Oct 1, 1989·The Journal of Clinical Investigation·S Ylä-HerttualaD Steinberg
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·S Ylä-HerttualaJ L Witztum
May 1, 1995·Clinical Immunology and Immunopathology·G VirellaM F Lopes-Virella
Apr 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·C BergmarkJ Swedenborg
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
Nov 28, 1994·Archives of Internal Medicine·M PuurunenT Palosuo
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 1, 1993·International Journal of Clinical & Laboratory Research·G VirellaM F Lopes-Virella
Feb 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M MironovaM F Lopes-Virella
Oct 1, 1995·Journal of Cardiovascular Risk·A N Orekhov Ruda MYa
Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M I UusitupaS Ylä-Herttuala
Nov 5, 1997·Clinical Immunology and Immunopathology·M MironovaM F Lopes-Virella
Aug 26, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·J HultheO Wiklund
Jan 15, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·T LehtimäkiT Nikkari
Mar 18, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M F Lopes-VirellaK Y Forrest
Jan 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·A T ErkkiläS Ylä-Herttuala
Apr 26, 2000·Clinical Immunology : the Official Journal of the Clinical Immunology Society·G VirellaM Lopes-Virella
Sep 25, 2002·Circulation·Göran K Hansson
Nov 19, 2002·Diabetologia·D H AtchleyG Virella
Dec 18, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·G VirellaUNKNOWN DCCT/EDIC Research Group
Feb 4, 2003·Journal of Lipid Research·Gabriel VirellaUNKNOWN DCCT/EDIC Research Group
Mar 4, 2003·Nature Medicine·Gabriel Virella, Maria F Lopes-Virella
Jun 6, 2003·The New England Journal of Medicine·David M NathanUNKNOWN Epidemiology of Diabetes Interventions and Complications Research Group
Jul 11, 2003·Clinical and Diagnostic Laboratory Immunology·Gabriel Virella, Maria F Lopes-Virella

❮ Previous
Next ❯

Citations

Oct 18, 2012·Journal of Clinical Immunology·Igor A SobeninAlexander N Orekhov
Feb 22, 2011·Current Diabetes Reports·Kristen J Nadeau, Jane E B Reusch
Apr 25, 2012·Journal of Cardiovascular Translational Research·Janet K Snell-Bergeon, Kristen Nadeau
Aug 4, 2012·Journal of the American Society of Nephrology : JASN·Virginia Lopez-ParraCarmen Gomez-Guerrero
Aug 24, 2013·Journal of Atherosclerosis and Thrombosis·Maria F Lopes-Virella, Gabriel Virella
Feb 13, 2009·Current Medical Research and Opinion·S DoganUNKNOWN OPAL investigators
Apr 8, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Richard J Quigg
Mar 29, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Souzan A AbdelsamieMaria F Lopes-Virella
Jul 8, 2010·Journal of Diabetes and Its Complications·Richard L KleinUNKNOWN DCCT/EDIC Research Group
Apr 24, 2009·Medicina clínica·Pablo Pérez-Martínez, Francisco Pérez-Jiménez
Oct 6, 2009·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Soner DoganUNKNOWN SMART Study Group
Jun 9, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·S Vigili de KreutzenbergA Avogaro
May 12, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Maria F Lopes-Virella, Gabriel Virella
Jun 3, 2008·Atherosclerosis·Gabriel Virella, Maria F Lopes-Virella
Jun 6, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Gabriel VirellaMaria F Lopes-Virella
Sep 12, 2012·Atherosclerosis·Maria F Lopes-VirellaUNKNOWN VADT Investigators
Nov 1, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Tanize do Espirito Santo FaulinDulcineia Saes Parra Abdalla
Apr 22, 2015·Journal of Diabetes and Its Complications·Yi-Peng SunHai-Feng Pan
Jul 24, 2014·BioMed Research International·Igor A SobeninAlexander N Orekhov
Dec 16, 2010·Atherosclerosis·Maria F Lopes-VirellaUNKNOWN DCCT/EDIC Research Group
Dec 3, 2014·International Journal of Biological Macromolecules·Firoz AkhterSaheem Ahmad
Oct 29, 2010·Diabetes·Maria F Lopes-VirellaUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
Jul 17, 2008·Diabetes Care·Maria F Lopes-VirellaUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group
Aug 27, 2016·Journal of Clinical Laboratory Analysis·Firoz AkhterSaheem Ahmad
Apr 17, 2010·Angiology·Dayangku Fatiha Pengiran BurutGordon A A Ferns
Dec 25, 2009·Circulation. Cardiovascular Genetics·Peter W F Wilson
May 25, 2018·Current Medicinal Chemistry·Maria F Lopes-Virella, Gabriel Virella
Jan 18, 2013·Journal of Immunoassay & Immunochemistry·Gabriel VirellaMaria F Lopes-Virella
May 11, 2018·Current Opinion in Lipidology·Alexander N Orekhov
Sep 20, 2019·BioMed Research International·Rui ZhangFang Liu
Aug 21, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel EngelbertsenEva Bengtsson
May 1, 2021·Journal of Clinical Medicine·Katariina Öörni, Petri T Kovanen
Aug 28, 2021·Biomedicines·Nataliya V MushenkovaAlexander N Orekhov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Clinical and Diagnostic Laboratory Immunology
Gabriel VirellaMaria F Lopes-Virella
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Aklilu A YishakTrevor J Orchard
© 2021 Meta ULC. All rights reserved